Nabriva Therapeutics PLC (NASDAQ:NBRV)

BATS BZX Real-Time Price
As of Mar 15
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Nabriva Therapeutics PLC have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a -33.33% decrease from the last price of 1.50.

Chart unavailable

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Hold stock in Nabriva Therapeutics PLC. This rating has held steady since January, when it was downgraded from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.28%
Growthannually 38.51%


Growthquarterly 7.54%
Growthannually 25.31%
Key to the earnings and sales forecast charts.